Skip to main content

Table 2 Antibiotic treatment courses administered prior to the isolation of an Extended-Spectrum Beta-Lactamase (ESBL) microorganism among hospitalized patients

From: Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital

Antibiotic treatment

ATC class

N (%)

Penicillins:

J01CE01

3 (3)

Aminopenicillins:

J01CA04/J01CA01

4 (4)

Carboxypenicillins:

  

   Temocillin:

J01CA17

3 (3)

Flucloxacillins:

J01CF05

5 (5)

Amoxicillin-clavulanate

J01CR02

14 (15)

Piperacillin-tazobactam:

J01CR05

16 (17)

Cephalosporins:

  

   Cefazolin:

J01DB04

22 (24)

   Cefuroxime:

J01DC02

11 (13)

   Ceftriaxone:

J01DD04

5 (5)

   Ceftazidime:

J01DD02

5 (5)

   Cefepime:

J01DE01

5 (5)

Meropenem:

J01DH02

3 (3)

Fluoroquinolones:

J01MA14/J01MA02

12 (13)

Aminoglycosides:

J01GB06/J01GB03

8 (9)